Evidence map›Paper›PMID 41133087›Full record

ArticleCureus2025

Successful Chemotherapy for Spontaneous Gastrosplenic Fistula in Diffuse Large B-Cell Lymphoma.

Yuto Mimura, Ruiko Yamano, Yui Chikagawa, Takashi Kagaya, Kinya Ohata

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuto MimuraDepartment of Hematology, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Ruiko YamanoDepartment of Hematology, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Yui ChikagawaDepartment of Hematology, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Takashi KagayaDepartment of Gastroenterology, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Kinya OhataDepartment of Hematology, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrosplenic fistula (GSF) is a rare condition associated with gastric or splenic lymphomas. Surgical resection is the most commonly reported treatment, as has been documented in previous studies. We herein report a case of GSF in a 59-year-old man with diffuse large B-cell lymphoma (DLBCL). The patient was successfully treated with chemotherapy alone without the need for surgical resection. Given the patient's advanced stage and the absence of gastrointestinal bleeding or perforation, chemotherapy was selected as the first-line treatment to avoid the risks associated with surgery. The patient received the R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) along with high-dose methotrexate and intrathecal chemotherapy. No complications related to the fistula were observed during treatment, and the patient achieved complete metabolic remission.

Indexed as

chemotherapy (ct)diffuse large b cell lymphoma (dlbcl)gastrosplenic fistulanonsurgical treatmentr-chop regimen

Identifiers

PMID41133087
PMCPMC12541538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.